AI company C3.ai, Inc. accused of securities law violations; affected investors advised to consult The Gross Law Firm before October 21, 2025 regarding potential legal action
News Article: Gross Law Firm Issues Notice to C3.ai, Inc. Shareholders
The Gross Law Firm, a nationally recognized class action law firm, has issued a notice to shareholders of C3.ai, Inc. (NYSE: AI). The notice is for shareholders who purchased shares of AI during the class period from February 26, 2025, to August 8, 2025.
According to the notice, the Company attributed its poor sales results and lowered guidance for the full fiscal year 2026 to a reorganization with new leadership and the health ailments of its CEO, Thomas Siebel. The complaint alleges that defendants provided false and misleading statements about C3 AI's growth during this period.
Notably, the complaint states that Siebel's health was having a significant impact on the Company's ability to close deals. The management's inability or ineffectiveness in minimizing this impact is also mentioned in the complaint.
Following this news, the price of C3 AI's common stock declined dramatically. From a closing market price of $22.13 per share on August 8, 2025, C3 AI's stock price fell to $16.47 per share on August 11, 2025, a decline of about 25.58% in a single day.
The deadline for shareholders to register for this class action is October 21, 2025. Appointment as lead plaintiff is not required to partake in any recovery. Shareholders are encouraged to contact the firm regarding possible lead plaintiff appointment.
The Gross Law Firm is committed to protecting investors who have suffered losses due to deceit, fraud, and illegal business practices. The recovery in question is related to share purchases of C3.ai, Inc. during the specified class period.
For more information and to submit a loss claim, shareholders can visit the following link: C3.ai, Inc. Loss Submission Form. The contact information for the Gross Law Firm is:
15 West 38th Street, 12th floor, New York, NY, 10018 Email: [email protected] Phone: (646) 453-8903
It is important for shareholders to take action if they believe they have been affected by the alleged misconduct.
